News
FDA leaders under President Donald Trump are moving to abandon a decades-old policy of asking outside experts to review drug ...
The agency's Digital Health Advisory Committee will meet on November 6 and focus on how these digital tools could help ...
Stocktwits on MSN2d
Travere Therapeutics Stock Soars Pre-market After FDA Waives Need For An Advisory Committee Meeting On Its Kidney Disorder Drug Application
Travere Therapeutics (TVTX) on Wednesday said that the U.S. Food and Drug Administration informed the company that it has ...
In today's Morning Rounds newsletter, NIH is finally spending down its coffers, FDA eyes tighter regulations on chatbots for ...
The U.S. Food and Drug Administration plans to fast-track reviews of four tobacco firms' nicotine pouches in a pilot program ...
Outlook Therapeutics seeks FDA clarity on ONS-5010 after a complete response letter, aiming to address efficacy concerns for ...
He relayed the message Tuesday at a meeting of health care product makers and Wednesday to an FDA advocacy group. In addition ...
BioAtla's ozuriftamab vedotin advances to phase 3 trials for HPV-positive oropharyngeal cancer, aiming for accelerated FDA ...
The FDA will convene its Digital Health Advisory Committee Nov. 6 to discuss the use of generative artificial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback